UK-Listed Consumer Goods Group Supreme Sees Vape Duty as Potential Consolidation Opportunity, Holds FY27 Outlook

Sep.18
UK-Listed Consumer Goods Group Supreme Sees Vape Duty as Potential Consolidation Opportunity, Holds FY27 Outlook
UK-listed consumer goods group Supreme plc says it continues to expect FY27 trading to meet market expectations as the Vaping Products Duty takes effect on October 1, while maintaining a comparatively positive view of the new tax and compliance regime. Supreme has said the framework could increase compliance complexity for smaller operators and contribute to market consolidation, while its manufacturing, compliance and distribution scale may allow it to gain share. Its 88Vape brand will retain its value positioning.

Key Points

  • Supreme continues to expect FY27 trading to be in line with market expectations; analyst consensus immediately before its latest update stood at £302.1 million of revenue and £39.6 million of adjusted EBITDA.
  • The UK's Vaping Products Duty starts October 1 at a flat £2.20 per 10ml of vaping liquid.
  • Supreme has publicly supported a more regulated and compliant vaping market and says the new regime could contribute to market consolidation.
  • Supreme's Vaping revenue increased 15% to £148.1 million in FY26, while its Manchester facility produces around 70 million 10ml e-liquid bottles annually.

2Firsts

September 18, 2026

UK-listed consumer goods group Supreme plc said in a September 17 trading update that it continues to expect results for the year ending March 31, 2027, to meet market expectations, less than two weeks before the UK's Vaping Products Duty takes effect.

Supreme also maintained a comparatively positive stance toward the new tax and compliance framework, saying it supports the government's objective of creating a more regulated and compliant vaping market.

In its FY26 results, the company went further, saying it expected market consolidation following the introduction of the duty and that smaller competitors with less financial and operational capacity could face a significant compliance burden.

Analyst consensus immediately before the latest announcement stood at £302.1 million of FY27 revenue and £39.6 million of adjusted EBITDA. Supreme said trading had started the financial year in line with expectations after investing almost £5 million in its brands so far this year.

Supreme Sees Scope for Market Consolidation

The UK's Vaping Products Duty takes effect on October 1, 2026.

Under HM Revenue & Customs rules, vaping liquid within the scope of the duty will be taxed at a flat rate of £2.20 per 10ml, or £0.22 per millilitre, regardless of whether it contains nicotine.

At that rate, a 10ml bottle carries £2.20 in duty and a 2ml pod carries £0.44. Supreme noted that a two-pack of 2ml pods would therefore attract £0.88 in duty, before VAT.

Rather than focusing solely on the additional cost, Supreme has described the regime as a potential business opportunity.

The company said its contract-manufacturing activity in the 10ml e-liquid segment has been growing and expects that trend could accelerate as smaller manufacturers face greater operational complexity under VPD.

Supreme has said its financial resources, manufacturing platform and compliance capabilities could allow it to gain market share as the sector consolidates.

Those are management expectations. VPD has yet to take effect, and its eventual impact on company exits, market shares and consumer demand has not yet been established by post-implementation market data.

Vaping Revenue Rose 15% in FY26

Vaping remains Supreme's largest operating division.

For the year ended March 31, 2026, Vaping revenue increased by £19.1 million, or 15%, to £148.1 million from £129.0 million a year earlier. Supreme said the growth was entirely organic, supported by expanded distribution of third-party brands including Hayati and IVG, entry into Spain and the rollout of pod devices following the UK's disposable vape ban.

The UK ban on the sale and supply of disposable vapes took effect on June 1, 2025. Supreme said its core 10ml e-liquid operation continued to see steady demand during FY26.

Its Manchester manufacturing facility produces approximately 70 million 10ml e-liquid bottles annually.

At group level, FY26 revenue rose 17% to £270.2 million. Adjusted EBITDA was broadly flat at £40.6 million, compared with £40.5 million a year earlier, while adjusted net cash increased to £7.5 million from £1.2 million.

88Vape Retains Value Positioning

Chief Executive Sandy Chadha said Supreme expects its 88Vape brand, which has long been positioned around value, to continue appealing to existing and new consumers as the new pricing regime takes effect.

Supreme did not disclose post-VPD retail pricing for 88Vape in its latest trading update.

Because the duty is levied at the same absolute rate per millilitre across products, vaping liquids of the same volume carry the same VPD liability regardless of their retail price. Supreme views 88Vape's value positioning as one element of its response to the new pricing environment, although any shift by consumers toward lower-priced products remains a company expectation rather than an observed post-tax market outcome.

Supreme operates across three divisions: Vaping, Drinks & Wellness, and Electricals & Household. The company says it has more than 3,000 active business accounts serving around 55,000 retail outlets.

Follow 2Firsts for timely updates on global tobacco and nicotine industry developments, corporate strategy and market trends.

Cover Image: TheBusinessDesk


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands reaffirmed its FY26 guidance in its October 8 pre-close trading update, forecasting double-digit net revenue growth in next-generation products and share gains across heated tobacco, vape and modern oral. Tobacco net revenue is expected to grow at a low-single-digit rate, marking a sixth consecutive year of growth. The company has completed its £1.45 billion FY26 share repurchase and announced a £1.5 billion buyback for FY27. Group adjusted operating profit is expected to increase 3% to 5%, while free cash flow is forecast to exceed £2.2 billion.
Oct.09
JTI Liggett Puts U.S. Value Cigarette Brands in Spotlight at 2026 NACS Show
JTI Liggett Puts U.S. Value Cigarette Brands in Spotlight at 2026 NACS Show
At the 2026 NACS Show in Las Vegas, JTI Liggett highlighted its value-priced cigarette portfolio, including LD and Montego, following JT Group's acquisition of Vector Group. The company's U.S. business reported market share gains, with LD sales volume rising 32.6% in the first half of 2026. Meanwhile, Ploom was displayed separately at Altria's booth under an existing partnership. JTI Liggett booth staff told 2Firsts that the company had not yet launched nicotine pouch products in the United States.
EXPO
Oct.09
RLX Technology Dropped From FTSE All-World as International Business Reaches 68.5% of Q2 Revenue
RLX Technology Dropped From FTSE All-World as International Business Reaches 68.5% of Q2 Revenue
RLX Technology (NYSE: RLX) has been removed from the FTSE All-World Index, effective September 21. FTSE Russell records show RLX was already part of its global equity index universe by 2022, when its American depositary receipts were classified as China Large Cap securities. Trading volume rose to about 44.77 million shares on September 18, roughly 23 times the previous session's volume. RLX reported RMB1.0105 billion in second-quarter revenue, up 14.8% year over year, with international operations contributing 68.5%. The company also acquired a 51% stake in one of Western Europe's largest distributors of next-generation smoke-free and FMCG products in July.
Sep.22
GSTHR Estimates 200 Million People Use Non-Combustible Nicotine Products as 28 Countries Show Rising Use Alongside Falling Smoking Rates
GSTHR Estimates 200 Million People Use Non-Combustible Nicotine Products as 28 Countries Show Rising Use Alongside Falling Smoking Rates
The Global State of Tobacco Harm Reduction, a project operated by Knowledge·Action·Change, estimates that about 200 million people worldwide use non-combustible nicotine products including vapes, heated tobacco, nicotine pouches and snus. Its 2026 report says use of these products rose alongside declining smoking rates in 28 countries it analyzed. The data do not establish that all 200 million users have quit smoking, nor do they prove a direct causal relationship. GSTHR also says regulatory restrictions on the products continue to expand in many markets.
Sep.10
PMI Expands Its Second Global and First Asian Business Services Hub in the Philippines, Serving 160 Markets and Scaling Up AI Capabilities
PMI Expands Its Second Global and First Asian Business Services Hub in the Philippines, Serving 160 Markets and Scaling Up AI Capabilities
Philip Morris International's PMI Business Solutions Philippines has expanded its global business services hub in Makati and plans to add more than 80 positions. Established in 2021 primarily to provide finance and IT support to about 20 markets, the center now employs 519 professionals delivering roughly 600 services across 160 markets. Its functions now span finance, human resources, IT, commercial operations, data analytics, supply chain and project management. PMI says the hub's next phase will focus on AI-enabled and higher-value work. The company did not disclose the size or investment cost of the expansion.
Sep.24
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
Ahead of the Formula 1 race in Madrid, 67 Spanish and international public-health, medical and consumer organizations have sent an open letter to F1 President and CEO Stefano Domenicali calling for an end to sponsorships linked to the tobacco and nicotine industry, including nicotine pouches, vaping products and heated tobacco. The letter focuses on Philip Morris International’s ZYN partnership with Ferrari and British American Tobacco’s long-running partnership with McLaren and exposure for VELO. The campaign follows a March letter in which more than 160 organizations worldwide made a similar request to Formula 1.
Sep.10